Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma

Bengs S, Becker E, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Britzen-Laurent N, Von Boehmer L, Knuth A, Tuomisto A, Makinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Vavricka SR, Halama M, Croner RS, Christoph J, Jenkins G, Sheppard D, Stürzl M, Fried M, Rogler G, Scharl M (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Swiss Medical Weekly Swiss Medical Publishers Ltd

Book Volume: 147

Pages Range: 9S-9S

Authors with CRIS profile

Nathalie Britzen-Laurent Professur für Molekulare und Experimentelle Chirurgie Jan Christoph Lehrstuhl für Medizinische Informatik Michael Stürzl Professur für Molekulare und Experimentelle Chirurgie

Involved external institutions

Universitätsspital Zürich (USZ)

Switzerland (CH) Hamad Medical Corporation

Qatar (QA) Oulun Yliopisto / University of Oulo

Finland (FI) See-Spital Horgen

Germany (DE) Universitätsspital Basel

Switzerland (CH) University of Nottingham

United Kingdom (GB) University of California San Francisco (UCSF)

United States (USA) (US) Stadtspital Triemli / Triemli Hospital

Switzerland (CH) Rockefeller University

United States (USA) (US)

How to cite

APA:

Bengs, S., Becker, E., Spalinger, M.R., Raselli, T., Kasper, S., Lang, S.,... Scharl, M. (2017). Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma. (pp. 9S-9S).

MLA:

Bengs, Susan, et al. "Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma." 2017. 9S-9S.

BibTeX: Download